Annual Net Income
$5.67 B
+$1.07 B+23.37%
31 December 2023
Summary:
Gilead Sciences annual net profit is currently $5.67 billion, with the most recent change of +$1.07 billion (+23.37%) on 31 December 2023. During the last 3 years, it has risen by +$5.54 billion (+4505.69%). GILD annual net income is now -68.72% below its all-time high of $18.11 billion, reached on 31 December 2015.GILD Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$1.25 B
-$361.00 M-22.37%
30 September 2024
Summary:
Gilead Sciences quarterly net profit is currently $1.25 billion, with the most recent change of -$361.00 million (-22.37%) on 30 September 2024. Over the past year, it has dropped by -$927.00 million (-42.52%). GILD quarterly net income is now -73.24% below its all-time high of $4.68 billion, reached on 31 December 2015.GILD Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$126.00 M
-$927.00 M-88.03%
30 September 2024
Summary:
Gilead Sciences TTM net profit is currently $126.00 million, with the most recent change of -$927.00 million (-88.03%) on 30 September 2024. Over the past year, it has dropped by -$5.75 billion (-97.86%). GILD TTM net income is now -99.30% below its all-time high of $18.11 billion, reached on 31 December 2015.GILD TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GILD Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +23.4% | -42.5% | -97.9% |
3 y3 years | +4505.7% | -51.7% | -98.3% |
5 y5 years | +3.9% | +207.6% | -95.3% |
GILD Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -9.0% | +4505.7% | -51.7% | +130.1% | -98.3% | at low |
5 y | 5 years | -9.0% | +4505.7% | -53.5% | +130.1% | -98.3% | +149.0% |
alltime | all time | -68.7% | +576.1% | -73.2% | +130.1% | -99.3% | +110.6% |
Gilead Sciences Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $1.25 B(-22.4%) | $126.00 M(-88.0%) |
June 2024 | - | $1.61 B(-138.7%) | $1.05 B(+117.6%) |
Mar 2024 | - | -$4.17 B(-391.8%) | $484.00 M(-91.5%) |
Dec 2023 | $5.67 B(+23.4%) | $1.43 B(-34.4%) | $5.66 B(-3.6%) |
Sept 2023 | - | $2.18 B(+108.6%) | $5.88 B(+7.1%) |
June 2023 | - | $1.04 B(+3.5%) | $5.48 B(-1.8%) |
Mar 2023 | - | $1.01 B(-38.4%) | $5.58 B(+21.6%) |
Dec 2022 | $4.59 B(-26.2%) | $1.64 B(-8.3%) | $4.59 B(+37.7%) |
Sept 2022 | - | $1.79 B(+56.4%) | $3.33 B(-19.4%) |
June 2022 | - | $1.14 B(+5921.1%) | $4.14 B(-8.4%) |
Mar 2022 | - | $19.00 M(-95.0%) | $4.51 B(-27.5%) |
Dec 2021 | $6.22 B(+4961.0%) | $382.00 M(-85.3%) | $6.22 B(-15.8%) |
Sept 2021 | - | $2.59 B(+70.3%) | $7.39 B(+43.2%) |
June 2021 | - | $1.52 B(-12.0%) | $5.16 B(+1615.0%) |
Mar 2021 | - | $1.73 B(+11.5%) | $301.00 M(+144.7%) |
Dec 2020 | $123.00 M(-97.7%) | $1.55 B(+330.8%) | $123.00 M(-90.3%) |
Sept 2020 | - | $360.00 M(-110.8%) | $1.27 B(-593.4%) |
June 2020 | - | -$3.34 B(-315.3%) | -$257.00 M(-105.2%) |
Mar 2020 | - | $1.55 B(-42.5%) | $4.96 B(-7.9%) |
Dec 2019 | $5.39 B(-1.3%) | $2.70 B(-331.4%) | $5.39 B(+100.0%) |
Sept 2019 | - | -$1.17 B(-162.0%) | $2.69 B(-54.8%) |
June 2019 | - | $1.88 B(-4.8%) | $5.96 B(+1.1%) |
Mar 2019 | - | $1.98 B(>+9900.0%) | $5.89 B(+8.0%) |
Dec 2018 | $5.46 B(+17.9%) | $3.00 M(-99.9%) | $5.46 B(+243.7%) |
Sept 2018 | - | $2.10 B(+15.4%) | $1.59 B(-28.1%) |
June 2018 | - | $1.82 B(+18.1%) | $2.21 B(-36.3%) |
Mar 2018 | - | $1.54 B(-139.8%) | $3.46 B(-25.2%) |
Dec 2017 | $4.63 B(-65.7%) | -$3.87 B(-242.2%) | $4.63 B(-60.1%) |
Sept 2017 | - | $2.72 B(-11.6%) | $11.60 B(-5.0%) |
June 2017 | - | $3.07 B(+13.7%) | $12.21 B(-3.4%) |
Mar 2017 | - | $2.70 B(-13.1%) | $12.64 B(-6.4%) |
Dec 2016 | $13.50 B(-25.4%) | $3.11 B(-6.7%) | $13.50 B(-10.4%) |
Sept 2016 | - | $3.33 B(-4.8%) | $15.08 B(-7.8%) |
June 2016 | - | $3.50 B(-1.9%) | $16.35 B(-5.7%) |
Mar 2016 | - | $3.57 B(-23.9%) | $17.34 B(-4.2%) |
Dec 2015 | $18.11 B(+49.6%) | $4.68 B(+1.8%) | $18.11 B(+7.1%) |
Sept 2015 | - | $4.60 B(+2.4%) | $16.91 B(+12.4%) |
June 2015 | - | $4.49 B(+3.7%) | $15.04 B(+5.9%) |
Mar 2015 | - | $4.33 B(+24.3%) | $14.21 B(+17.4%) |
Dec 2014 | $12.10 B(+293.5%) | $3.49 B(+27.7%) | $12.10 B(+28.7%) |
Sept 2014 | - | $2.73 B(-25.3%) | $9.41 B(+26.0%) |
June 2014 | - | $3.66 B(+64.2%) | $7.46 B(+63.0%) |
Mar 2014 | - | $2.23 B(+181.3%) | $4.58 B(+48.9%) |
Dec 2013 | $3.08 B(+18.6%) | $791.60 M(+0.4%) | $3.08 B(+0.9%) |
Sept 2013 | - | $788.61 M(+2.1%) | $3.05 B(+3.9%) |
June 2013 | - | $772.61 M(+7.0%) | $2.93 B(+2.1%) |
Mar 2013 | - | $722.19 M(-5.3%) | $2.87 B(+10.8%) |
Dec 2012 | $2.59 B(-7.5%) | $762.98 M(+12.9%) | $2.59 B(+3.9%) |
Sept 2012 | - | $675.50 M(-5.1%) | $2.49 B(-2.6%) |
June 2012 | - | $711.56 M(+61.0%) | $2.56 B(-1.3%) |
Mar 2012 | - | $441.96 M(-33.6%) | $2.59 B(-7.5%) |
Dec 2011 | $2.80 B(-3.4%) | $665.14 M(-10.3%) | $2.80 B(+1.3%) |
Sept 2011 | - | $741.12 M(-0.7%) | $2.77 B(+1.3%) |
June 2011 | - | $746.23 M(+14.6%) | $2.73 B(+1.3%) |
Mar 2011 | - | $651.14 M(+3.5%) | $2.70 B(-7.0%) |
Dec 2010 | $2.90 B(+10.1%) | $629.42 M(-10.7%) | $2.90 B(-5.6%) |
Sept 2010 | - | $704.88 M(-1.0%) | $3.07 B(+1.0%) |
June 2010 | - | $712.06 M(-16.7%) | $3.04 B(+4.8%) |
Mar 2010 | - | $854.90 M(+6.6%) | $2.90 B(+10.1%) |
Dec 2009 | $2.64 B(+33.2%) | $802.21 M(+19.2%) | $2.64 B(+11.2%) |
Sept 2009 | - | $673.03 M(+17.8%) | $2.37 B(+7.7%) |
June 2009 | - | $571.40 M(-3.0%) | $2.20 B(+6.6%) |
Mar 2009 | - | $589.11 M(+9.9%) | $2.06 B(+5.1%) |
Dec 2008 | $1.98 B(+22.5%) | $535.94 M(+6.3%) | $1.96 B(+7.3%) |
Sept 2008 | - | $504.00 M(+15.9%) | $1.83 B(+6.1%) |
June 2008 | - | $434.78 M(-11.0%) | $1.72 B(+1.6%) |
Mar 2008 | - | $488.30 M(+21.6%) | $1.70 B(+5.0%) |
Dec 2007 | $1.62 B | $401.64 M(+0.8%) | $1.62 B(-457.4%) |
Sept 2007 | - | $398.32 M(-2.4%) | -$451.99 M(-49.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2007 | - | $407.93 M(+0.1%) | -$902.47 M(-13.7%) |
Mar 2007 | - | $407.41 M(-124.5%) | -$1.05 B(-12.2%) |
Dec 2006 | -$1.19 B(-246.2%) | -$1.67 B(+3093.1%) | -$1.19 B(-257.1%) |
Sept 2006 | - | -$52.16 M(-119.7%) | $757.29 M(-23.4%) |
June 2006 | - | $265.15 M(+0.9%) | $988.69 M(+7.5%) |
Mar 2006 | - | $262.70 M(-6.7%) | $919.50 M(+13.0%) |
Dec 2005 | $813.91 M(+81.1%) | $281.60 M(+57.1%) | $813.91 M(+26.7%) |
Sept 2005 | - | $179.23 M(-8.5%) | $642.56 M(+11.4%) |
June 2005 | - | $195.97 M(+24.7%) | $576.56 M(+17.2%) |
Mar 2005 | - | $157.11 M(+42.5%) | $492.06 M(+9.5%) |
Dec 2004 | $449.37 M(-724.1%) | $110.24 M(-2.6%) | $449.37 M(-15.5%) |
Sept 2004 | - | $113.24 M(+1.6%) | $531.71 M(+8.2%) |
June 2004 | - | $111.46 M(-2.6%) | $491.57 M(+2.3%) |
Mar 2004 | - | $114.43 M(-40.6%) | $480.48 M(-767.3%) |
Dec 2003 | -$72.00 M(-199.9%) | $192.58 M(+163.5%) | -$72.00 M(-68.6%) |
Sept 2003 | - | $73.10 M(-27.2%) | -$229.11 M(-18.6%) |
June 2003 | - | $100.37 M(-122.9%) | -$281.45 M(-22.3%) |
Mar 2003 | - | -$438.05 M(-1334.7%) | -$362.11 M(-602.2%) |
Dec 2002 | $72.10 M(+37.9%) | $35.48 M(+70.9%) | $72.10 M(-57.1%) |
Sept 2002 | - | $20.76 M(+5.3%) | $168.19 M(+37.6%) |
June 2002 | - | $19.71 M(-612.0%) | $122.24 M(+74.3%) |
Mar 2002 | - | -$3.85 M(-102.9%) | $70.14 M(+34.2%) |
Dec 2001 | $52.27 M(-192.1%) | $131.58 M(-622.2%) | $52.27 M(-148.1%) |
Sept 2001 | - | -$25.20 M(-22.2%) | -$108.57 M(+7.6%) |
June 2001 | - | -$32.39 M(+49.1%) | -$100.94 M(+39.1%) |
Mar 2001 | - | -$21.72 M(-25.8%) | -$72.59 M(+2.1%) |
Dec 2000 | -$56.78 M(-14.6%) | -$29.27 M(+66.6%) | -$71.08 M(+39.9%) |
Sept 2000 | - | -$17.56 M(+335.2%) | -$50.81 M(-20.2%) |
June 2000 | - | -$4.04 M(-80.0%) | -$63.65 M(-10.7%) |
Mar 2000 | - | -$20.21 M(+124.6%) | -$71.30 M(+7.1%) |
Dec 1999 | -$66.50 M(+48.4%) | -$9.00 M(-70.4%) | -$66.57 M(-12.7%) |
Sept 1999 | - | -$30.40 M(+160.0%) | -$76.27 M(+74.7%) |
June 1999 | - | -$11.69 M(-24.5%) | -$43.67 M(-6.6%) |
Mar 1999 | - | -$15.48 M(-17.2%) | -$46.78 M(+20.9%) |
Dec 1998 | -$44.80 M(-38.5%) | -$18.70 M(-950.0%) | -$38.70 M(-49.9%) |
Sept 1998 | - | $2.20 M(-114.9%) | -$77.30 M(-13.9%) |
June 1998 | - | -$14.80 M(+100.0%) | -$89.80 M(+24.2%) |
Mar 1998 | - | -$7.40 M(-87.1%) | -$72.30 M(-0.7%) |
Dec 1997 | -$72.90 M(+235.9%) | -$57.30 M(+456.3%) | -$72.80 M(+209.8%) |
Sept 1997 | - | -$10.30 M(-481.5%) | -$23.50 M(+502.6%) |
June 1997 | - | $2.70 M(-134.2%) | -$3.90 M(-79.3%) |
Mar 1997 | - | -$7.90 M(-1.3%) | -$18.80 M(-13.4%) |
Dec 1996 | -$21.70 M(-20.8%) | -$8.00 M(-186.0%) | -$21.70 M(+58.4%) |
Sept 1996 | - | $9.30 M(-176.2%) | -$13.70 M(-56.4%) |
June 1996 | - | -$12.20 M(+13.0%) | -$31.40 M(+15.9%) |
Mar 1996 | - | -$10.80 M(+28.6%) | -$27.10 M(-18.9%) |
Dec 1995 | -$27.40 M(-12.5%) | - | - |
Sept 1995 | - | -$8.40 M(+6.3%) | -$33.40 M(+4.4%) |
June 1995 | - | -$7.90 M(-11.2%) | -$32.00 M(+2.2%) |
Mar 1995 | - | -$8.90 M(+8.5%) | -$31.30 M(+1.6%) |
Mar 1995 | -$31.30 M(+21.8%) | - | - |
Dec 1994 | - | -$8.20 M(+17.1%) | -$30.80 M(+5.1%) |
Sept 1994 | - | -$7.00 M(-2.8%) | -$29.30 M(+4.3%) |
June 1994 | - | -$7.20 M(-14.3%) | -$28.10 M(+9.3%) |
Mar 1994 | -$25.70 M(+82.3%) | -$8.40 M(+25.4%) | -$25.70 M(+11.7%) |
Dec 1993 | - | -$6.70 M(+15.5%) | -$23.00 M(+13.9%) |
Sept 1993 | - | -$5.80 M(+20.8%) | -$20.20 M(+18.1%) |
June 1993 | - | -$4.80 M(-15.8%) | -$17.10 M(+21.3%) |
Mar 1993 | -$14.10 M(+213.3%) | -$5.70 M(+46.2%) | -$14.10 M(+45.4%) |
Dec 1992 | - | -$3.90 M(+44.4%) | -$9.70 M(+36.6%) |
Sept 1992 | - | -$2.70 M(+50.0%) | -$7.10 M(+34.0%) |
June 1992 | - | -$1.80 M(+38.5%) | -$5.30 M(+20.5%) |
Mar 1992 | -$4.50 M(+12.5%) | -$1.30 M(0.0%) | -$4.40 M(+7.3%) |
Dec 1991 | - | -$1.30 M(+44.4%) | -$4.10 M(+10.8%) |
Sept 1991 | - | -$900.00 K(0.0%) | -$3.70 M(-2.6%) |
June 1991 | - | -$900.00 K(-10.0%) | -$3.80 M(-2.6%) |
Mar 1991 | -$4.00 M | -$1.00 M(+11.1%) | -$3.90 M(+34.5%) |
Dec 1990 | - | -$900.00 K(-10.0%) | -$2.90 M(+45.0%) |
Sept 1990 | - | -$1.00 M(0.0%) | -$2.00 M(+100.0%) |
June 1990 | - | -$1.00 M | -$1.00 M |
FAQ
- What is Gilead Sciences annual net profit?
- What is the all time high annual net income for Gilead Sciences?
- What is Gilead Sciences annual net income year-on-year change?
- What is Gilead Sciences quarterly net profit?
- What is the all time high quarterly net income for Gilead Sciences?
- What is Gilead Sciences quarterly net income year-on-year change?
- What is Gilead Sciences TTM net profit?
- What is the all time high TTM net income for Gilead Sciences?
- What is Gilead Sciences TTM net income year-on-year change?
What is Gilead Sciences annual net profit?
The current annual net income of GILD is $5.67 B
What is the all time high annual net income for Gilead Sciences?
Gilead Sciences all-time high annual net profit is $18.11 B
What is Gilead Sciences annual net income year-on-year change?
Over the past year, GILD annual net profit has changed by +$1.07 B (+23.37%)
What is Gilead Sciences quarterly net profit?
The current quarterly net income of GILD is $1.25 B
What is the all time high quarterly net income for Gilead Sciences?
Gilead Sciences all-time high quarterly net profit is $4.68 B
What is Gilead Sciences quarterly net income year-on-year change?
Over the past year, GILD quarterly net profit has changed by -$927.00 M (-42.52%)
What is Gilead Sciences TTM net profit?
The current TTM net income of GILD is $126.00 M
What is the all time high TTM net income for Gilead Sciences?
Gilead Sciences all-time high TTM net profit is $18.11 B
What is Gilead Sciences TTM net income year-on-year change?
Over the past year, GILD TTM net profit has changed by -$5.75 B (-97.86%)